Podcasts about Arrhythmia

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Welcome, MedTech Gurus! Imagine a world where artificial intelligence and remote monitoring work together to detect and prevent life-threatening cardiac conditions before they escalate. That's exactly what today's guest, Stuart Long, CEO of InfoBionic.AI, is pioneering. With over 20 years in the medical device industry and leadership experience at companies like Monarch Medical Systems and CapsuleTech, Stuart is no stranger to driving transformative change in healthcare. At InfoBionic.AI, he's leading the charge in AI-powered remote cardiac monitoring, revolutionizing how arrhythmias—especially atrial fibrillation (A-Fib)—are detected, treated, and prevented. In this episode, we'll dive into how real-time, continuous monitoring is reshaping cardiac care, improving patient outcomes, and reducing hospital readmissions. Stay tuned—this is an episode you won't want to miss!

With Jean-Claude Deharo, Hospital La Timone Adults, Marseille - France, Professor Fabien Praz, Inselspital Bern - Switzerland, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Vera Maslova, University Medical Center of Schleswig-Holstein, Kiel - Germany. This episode will tackle the EHRA Consensus document on management of patients with transvalvular leads undergoing percutaneous tricuspid clave interventions, focusing on assessment, procedural insights, post-procedure care, and expert perspectives.

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

Experts explore and summarize the epidemiology of arrhythmias seen during pregnancy and in the postpartum period. The discussion includes guideline directed treatment for arrhythmias during pregnancy incorporating the safety of medications and invasive treatments, as well as recommendations for care during postpartum. 

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Jill Pell from the University of Glasgow. They discuss her team's paper on walking speed and the risk of future arrhythmia. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: https://heart.bmj.com/content/early/2025/04/10/heartjnl-2024-325004

Association Between COVID-19 Vaccination and Atrial Arrhythmias in Individuals with Cardiac Implantable Electronic Devices   Guest: Malini Madhavan, M.B.B.S. Host: Anthony H. Kashou, M.D.   In a study of over 7000 individuals with a cardiac implanted device in the Biotronik CERTITUDE registry, the burden of device detected AF was noted to be higher in the 3 months after covid vaccination compared to the 3 months preceding vaccination. A similar trend was observed for Influenza vaccinated individuals. However, when comparing a propensity matched group of controls without COVID vaccination, the trend towards increased burden of AF was similar in the 2 groups. This led the authors to conclude that the observed increase in AF burden represents the natural progression of AF risk rather than vaccine related changes.   Topics Discussed: The study of atrial fibrillation burden after COVID vaccination, including the conclusion. How the incidence of AF after COVID 19 vaccination compares to that after influenza vaccination. Other studies that have investigated arrhythmia occurrence after COVID vaccination. Safety for patients with cardiovascular disease to get vaccinated for COVID 19. References: https://www.heartrhythmjournal.com/article/S1547-5271(22)00914-6/fulltext https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.16372 https://pmc.ncbi.nlm.nih.gov/articles/PMC9175153/#:~:text=A%20total%20of%202611%20events,COVID%2D19%20vaccine%20doses%20administered Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

This episode covers: Cardiology This Week: A concise summary of recent studies Current indications for pulmonary vein isolation Conduction system pacing EHRA 2025 scientific highlights Host: Susanna Price Guests: Haran Burri, Isabel Deisenhofer, Helmut Puererfellner, Emma Svennberg Want to watch that episode? Go to: https://esc365.escardio.org/event/1803   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Isabel Deisenhofer has declared to have potential conflicts of interest to report: speaker honoraria and travel grants from Abbott Medical, Biosense-Webster, Boston Scientific, BMS, Volta Medical, and research grant (for the institution) from Abbott Medical and Daiichi Sankyo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Helmut Puererfellner has declared to have potential conflicts of interest to report: speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member, etc., including travel funding related to these activities for the following companies: Abbott, Biotronik, Biosense Webster, Boston Scientific, Daiichi Sankyo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

With Giovanni Donato Aquaro, University of Pisa - Italy, and Carmelo De Gori, Fondazione Monasterio, Pisa - Italy. Link to editorial Link to paper  

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Stelios Tzeis, Mitera Hospital, Athens - Greece, and Natasja de Groot, Erasmus University Medical Centre, Rotterdam - The Netherlands, and Dominik Linz, Maastricht University Medical Centre (MUMC), Maastricht - The Netherlands. During this podcast Stefan Simovic, Natasja de Groot, Stylianos Tzeis and Dominik Linz will tackle the EHRA 2025 Highlights  (scientific breakthroughs, major trial results, latest news on in catheter ablation and leadless pacing). 

Focus Issue on Arrhythmias and Epidemiology, Prevention, and Health Care Policies

This episode covers: Cardiology This Week: A concise summary of recent studies Relevance and management of ventricular ectopic beats  Lp(a) in cardiovascular risk management Mythbusters: A vegetarian diet lowers cardiovascular risk Host: Susanna Price Guests: Carlos Aguiar, Thomas Deneke, Kausik Ray Want to watch that episode? Go to: https://esc365.escardio.org/event/1802 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Thomas Deneke, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Kausik Ray declared to have potential conflicts of interest to report: research grants from Amarin, Amgen, Daiichi Sankyo, Merck Sharp & Dohme, Pfizer, Regeneron, and Sanofi, consultant for Abbott, Amarin, Amgen, AstraZeneca, Bayer, Biologix, Boehringer Ingelheim, Cargene Therapeutics, CRISPR, CSL Behring, Eli Lilly and Company, Esperion, Kowa Pharmaceuticals, NewAmsterdam Pharma, Novartis, Novo Nordisk, Pfizer, Regeneron, Resverlogix, Sanofi, Scribe Therapeutics, Silence Therapeutics, Vaxxinity, and Viatris, honoraria for lectures from Novartis, BI, AZ, Novo Nordisk, Viatris, Amarin, Biologix Pharma, Sanofi, Amgen, Esperion, Daiichi Sankyo, Macleod and stock options New Amsterdam Pharma, Pemi 31, SCRIBE Therapeutics. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Susanna Price  Guest: Thomas Deneke  Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1802?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Thomas Deneke, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Sodium-Glucose Cotransporter-2 Inhibitors and Arrhythmias: A Meta-Analysis of 38 Randomized Controlled Trials

Cardiac monitoring “is a space that hasn’t seen disruption or innovation for 50 to 60 years, and we’re trying to disrupt that with our AI-powered Zio platform,” iRhythm CEO Quentin Blackford tells Bloomberg Intelligence. “And really, the focus is on how do we enable an earlier, more accurate diagnosis while reducing the workflow effects for our physicians?” In this episode of the Vanguards of Health Care podcast, Blackford sits down with BI analyst Matt Henriksson to talk about iRhythm, how its Zio-platform technology powered by its AI network allows patients to be monitored without disrupting their everyday lives, and how its clinical data could support a more proactive screening of patients to find arrhythmias before a catastrophic adverse event occurs.See omnystudio.com/listener for privacy information.

Can you exercise with AFib? Know someone with AFib—maybe a parent or loved one—who wants to stay active but isn't sure how? In this episode, Dr. Sean Swearingen, sports cardiologist, breaks down exactly how you can stay active while managing atrial fibrillation, without putting your heart at risk. Whether you're new to AFib or just looking to get back into exercise, you'll get expert advice on safe workouts, heart health monitoring, and when to reach out to your cardiologist. In This Episode, You'll Learn: Exercising with AFib: Why staying active is crucial for your heart, and how to safely incorporate exercise into your routine if you have AFib. How to Start Safely: Starting or returning to exercise after an AFib diagnosis? Dr. Swearingen shares the best tips for building up your fitness gradually and safely. Heart Rate Monitoring: The best tools to track your heart health during workouts, including the Zio Patch and Apple Watch, to make sure your AFib stays under control. When to Consult Your Cardiologist: How to know when it's time to check in with your cardiologist, and how to get personalized advice on exercising with AFib. The Role of Sports Cardiology: Why seeing a sports cardiologist can be a game-changer for safely managing AFib while staying fit. Who Should Listen: Anyone living with, or knows someone living with, AFib who wants to get back into exercise safely. People interested in sports cardiology and how it can help you stay active with heart conditions. Anyone who wants to learn to have a healthier heart Resources Mentioned in This Episode: Rush University Sports Cardiology: Learn more about Dr. Swearingen's sports cardiology practice here. Apple Watch: A great tool for tracking heart rate and rhythm during exercise. Find out more here. Zio Patch: Continuous heart monitoring for those with AFib. Learn more here. American Heart Association: Exercise tips and guidelines for those with heart conditions. Check out their recommendations here. Why You Should Listen: If you've been diagnosed with AFib, you're not alone. But that doesn't mean you have to stop being active. Dr. Swearingen gives you the expert advice you need to stay safe, stay fit, and stay healthy with AFib. Don't miss out—tune in now! Connect with Us: Please sign up for our SUBSTACK so you can forward this information to all your friends inboxes! For more episodes, merch, or to send us direct messages: Website: https://yourdoctorfriendspodcast.com Email: yourdoctorfriendspodcast@gmail.com Socials: Follow @your_doctor_friends on Instagram, TikTok, and YouTube. DM or send us a voice memo—we might feature it on the show! atrial fibrillation, AFib, exercise with AFib, heart health, sports cardiology, heart monitoring devices, Zio Patch, Apple Watch, managing AFib with exercise, post-COVID heart health, exercise guidelines for heart disease, living with AFib, sports cardiology, arrhythmias, fitness for heart patients

EP Lab Digest talks with Nishtha Sareen, MD, MPH, FACC, FSCAI, Medical Director, Women's Heart Clinic, Ascension Medical Group, about challenges in cardiovascular care for women, gaps in knowledge, considerations during pregnancy and menopause, differences in response to medical therapy, and more.

In this episode of Thinking Thoracic, Dr. Jane Yanagawa talks with Dr. Olujimi Ajijola, UCLA Health, about cardiac sympathetic denervation. They cover the basics, such as indications for CSD, and the latest advances to make surgery less invasive. The focus is on patients with severe ventricular arrhythmias for whom none of the conventional therapies available are effective. Listen today.

Rasa Kaye continues her conversation with Deborah cardiac electrophysiologist Raffaele Corbisiero, MD outlining the most common symptoms of arrhythmias and more.

Focus Issue on Arrhythmias, Digital Health, and Innovation

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, and Gregory Y.H. Lip, University of Liverpool, Liverpool - UK. This episode will tackle the current status and management of subclinical atrial fibrillation and atrial high rate episodes.

Advancements in arrhythmia care are transforming patient outcomes and reshaping clinical practices. Join Dr. Sanjiv Narayan, Professor of Medicine at Stanford University, and Dr. Paul Wang, Professor of Medicine and of Bioengineering at Stanford University, as they explore the evolving field of electrophysiology, highlighting the importance of early detection and best practices in the management of common electrical abnormalities. Discover how a patient-centered approach can enhance care and outcomes for those with irregular heart rhythms. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode99 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3229

Post-Cardiac Ablation Atrial Arrhythmia Monitoring   Guest: Suraj Kapa, M.D. Host: Anthony H. Kashou, M.D.   In this episode of the segment "ECG Making Waves," the listener will learn to identify the right monitoring approach for a given patient's arrhythmia considerations around ablation. They will also learn how to list specific considerations when reviewing and interpreting post-ablation arrhythmia ECGs.   Topics Discussed: What specific aspects of the ECG and ECG monitoring are important to look for after cardiac ablation? How do you approach rhythm monitoring discussions with your patients after ablation? What are potential benefits and pitfalls of different monitoring approaches for atrial arrhythmias after ablation?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

With Federico Fortuni and Claudio Bernetti, University of Perugia, Perugia - Italy Link to paper Link to editorial

The Endocannabinoid System plays a crucial role in regulating cardiovascular, neurological, and immune functions through CB1 and CB2 receptors. • CB1 Activation: Associated with oxidative stress, inflammation, and increased cardiovascular risks such as myocardial infarction (MI), arrhythmias, and heart failure. • CB2 Activation: Primarily found in immune cells and linked to anti-inflammatory and protective cardiovascular effects. • Cannabis Use: High THC content or synthetic cannabinoids (e.g., Spice, K2) significantly increases the risk of cardiovascular diseases and psychiatric disorders. • Cannabis Use Disorder (CUD): Characterized by compulsive use despite adverse consequences, often co-occurring with depression, PTSD, and anxiety. • Potential Therapeutic Targets: CB1 antagonists (e.g., Genistein) and CB2 agonists are being explored for their ability to reduce inflammation and vascular damage while minimizing psychiatric side effects.   Future research is needed to clarify long-term cardiovascular effects, optimize cannabinoid therapies, and inform public health policies.

This week on Health Matters, as we continue to observe Heart Month, we will explore the role that genetics play in heart health.Understanding your family history of cardiovascular health is essential. In fact, about 30% of heart disease can be linked to family history. We speak with Dr. Jessica Hennessy, a clinical cardiac electrophysiologist and cardiogenetics expert at NewYork-Presbyterian and Columbia to help break down which heart conditions and risk factors may be inherited. She provides valuable insight on effectively managing heart health, including the importance of lifestyle modifications in preventing heart disease, including for individuals with a genetic predisposition. She also explains who should get genetic testing and what that process looks like.___ Dr. Jessica Hennessey specializes in Cardiac Electrophysiology, with a special focus on Sports & Exercise Cardiology. She practices primarily in New York, NY, and is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Hennessey graduated from Duke University School of Medicine in 2014, and completed her training at Massachusetts General Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Columbia University Irving Medical Center. She is board certified in Internal Medicine, Cardiovascular Disease and Cardiac Electrophysiology. ___ Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday. If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

Commentary by Dr.  Jian'an Wang

In this episode of JACC, Dr. Valentin Fuster explore the 2024 ACC Expert Consensus on arrhythmia monitoring following a stroke, outlining critical insights on stroke types, arrhythmia detection, and anticoagulation strategies. The discussion highlights the complexities of identifying atrial fibrillation post-stroke and the challenges of choosing optimal antithrombotic therapy in diverse stroke cases.

Arrhythmias can occur anywhere in the heart, and where they occur is very important,” said Deborah cardiac electrophysiologist Raffaele Corbisiero, MD “because they carry different prognostic factors.” Listen to learn more about understanding arrhythmias as Rasa Kaye unpacks signs and what to look for with Deborah cardiac electrophysiologist Raffaele Corbisiero, MD.

With Lucas Boersma, St.Antonius Hospital, Nieuwegein - The Netherlands, and Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia. Join us for an exciting episode on non-transvenous ICDs, exploring their advantages and future potential.  

In this episode of "In the Rhythm," we welcome Drs. Hawkins Gay from Northwestern Medicine and Mohamed Elshazly of Orlando Health to explore the transformative role of artificial intelligence in Electrophysiology. Join us as they delve into the innovative ways AI is reshaping the diagnosis, prediction, and treatment of arrhythmias, from enhancing patient outcomes to streamlining clinical workflows.

With Markus Meyer, Lillehei Heart Institute, University of Minnesota - USA, Tim Van Loon and Joost Lumens, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Link to paper Link to editorial

Board-Certified cardiologist, Thomas Levy, MD, JD, has taught us the benefits of vitamin C, hydrogen peroxide, and how toxins in the mouth can cause disease. We completed The Roadmap to Health and Optimal Treatment of Disease virtual workshops that are now available to you online. Dr. Levy has a way of bringing a new awareness […]

This week we review a recent report that asks the question, 'Do all infants who present with SVT require preventive anti-arrhythmic medical therapy?' Who might be a candidate for not using an anti-arrhythmia medication in infancy? What sort of parental education is needed to potentially not use medicine and how do patients not treated compare to those who were treated with anti-arrhythmics in regards to re-admission or presentation to the emergency department or development of tachycardia induced cardiomyopathy? How should parents assess their infants for SVT at home? How long should infants be monitored prior to discharge to home after a single uncomplicated episode of SVT? We speak with Assistant Professor of Pediatrics at Washington University and the first author of this week's work, Dr. Anthony Pompa. DOI: 10.1007/s00246-023-03263-1

With Doctor Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Serge Trines, Leiden University Medical Center, Leiden - The Netherlands and Philip Moore, St Bartholomew's Hospital, London - UK This episode focuses on the EHRA Updated Core Curriculum.

Commentary by Dr. Matthew Ahmadi.

With Irene Carrion-Sanchez and Jose Luis Zamorano, Ramon and Cajal University Hospital, Madrid - Spain. Link to paper Link to editorial

Arrhythmias in Pregnancy   Guest: Katie A. Young, M.D. Guest: Abhishek J. Deshmukh, M.B.B.S. Host: Paul A. Friedman, M.D.   This episode dives into the complex and fascinating world of arrhythmia management during pregnancy, exploring how unique physiological changes can increase arrhythmia risk and impact treatment approaches. We'll discuss common and high-risk arrhythmias, management strategies and the importance of a collaborative care approach involving specialists across disciplines.   Topics Discussed: Identify the primary risk factors and physiological changes that contribute to arrhythmias in pregnant patients. Describe evidence-based management strategies for common and high-risk arrhythmias during pregnancy, including considerations for medication and procedural interventions. Recognize the role of interdisciplinary care in managing arrhythmias in pregnancy to ensure optimal maternal and fetal outcomes.   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.  

With Shinwan Kany, The University Medical Center Hamburg-Eppendorf, Hamburg - Germany, and Shaan Khurshid, Massachusetts General Hospital and Harvard Medical School - USA. Link to paper Link ton editorial

Focus Issue on Arrhythmias

Send us a textIt's already Episode 20 of Season 2 as we roll into winter 2024.Again this week the boy's are lucky to have two Guests Bethany Keime and Charlie Kirkman, both have different heart conditions, Bathany and twin sister Hannah both suffer from Hypertropic Cardiomyopathy whilst Charlie has Arrhythmia.Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles.This is  is most often caused by abnormal genes in the heart muscle. These genes cause the walls of the heart chamber (left ventricle) to become thicker than normal. The thickened walls may become stiff and this can reduce the amount of blood taken in and pumped out to the body with each heartbeat.How is hypertrophic cardiomyopathy treated?Activity limits. ...Preventing dehydration. ...Medicines to treat shortness of breath and chest pain. ...Medicines to help prevent abnormal heart rhythms. ...Anticoagulants. ...Septal myectomy. ...Alcohol septal ablation. ...Implantable cardioverter defibrillator (ICD).An Arrhythmia, or irregular heartbeat, is a problem with the rhythm or rate of your heartbeat. Your heart may beat too quickly, too slowly, or with an irregular rhythm. It is normal for your heart rate to speed up during physical activity and to slow down while resting or sleeping but with Arrhythmia this can be irregular anytime.While Arrhythmias can be a serious condition that can affect your health, there are also treatments available to help. By following a treatment plan and making heart healthy lifestyle changes, you can learn how to live with a cardiac arrhythmia.In today's Interview Bethany & Charlie tell us openly and honestly about their conditions from diagnosis to how the deal with it today and in everyday life.Bethany & sister Hannah are two remarkable twins who have taken this illness head on and realised there are others like themselves undiagnosed. Their experience as young teenagers soon discovered there was little information available and resorted to Google to explore their condition. Social Media Patient Community did not exist, so Bethany & Hannah set about correcting this by starting their own Social media presence "Heart Charged" in hope to reach out to those with this condition and those still to be diagnosed.They made us aware that as young women it was hard to get healthcare professionals to take them seriously with their health issues, simply sidelining them and saying "It's all part of growing up as a young Women"  It wasn't until a member of the family discovered they had hypertrophic cardiomyopathy that both Bethany & Hannah were then checked for this Condition.These young women have gone from strength to strength and this is how they met Charlie through Their social media connections and recent success with the "Sudden Cardiac Art" Exhibition in the UK, now destined for Southern California.#getheartcharged#charliekirkman# Stroke# Subarachnoid hemorrhage#Mediastinal Germ Cell Tumour#Prostate Cancer#Bronchiectasis#CharcotmarietoothDisease#Emphysema#The after life#Ghosts#Spirts#Ouija boards#Mediums#Psychics#Reincarnation#HeartTransplant#EbsteinsAnomaly#RareCondition#HealthJourney#LifeChangingDiagnosis#MentalHealth#Vulnerability#SelfCompassion#PostTraumaticGrowth#MedicalMiracle#BBCSports#Inspiration#Cardiology#Surgery#Podcast#HealthcareCheck out our website at www.whostomanddick.com

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on arrhythmias in patients with heart failure prescribed dofetilide or sotalol.

Did you miss AHA 2024? Listen here to brief discussions of the latest research. Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. DOI: 10.1056/NEJMe2414471.

Did you miss AHA 2024? Listen here to brief discussions of the latest research. Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med. DOI: 10.1056/NEJMe2414475.

Arrhythmias are on the rise, coinciding with an increase in stroke cases. In this interview, Karolyn A. Gazella talks with conventionally trained cardiologist Benjamin Remo, MD, who also recently completed a fellowship in integrative medicine. Dr Remo is a cardiologist with CHRISTUS Health in New Mexico and employs a more holistic approach to treating arrhythmias. About the Author Benjamin Remo, MD, is a cardiologist and electrophysiologist with the Lovelace Health System in Albuquerque, NM, and CHRISTUS Health in Santa Fe, NM. Dr Remo received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his internal medicine residency and cardiology fellowship at the New York University School of Medicine, followed by a fellowship in electrophysiology at the University of Maryland School of Medicine. More recently, he completed a fellowship in integrative medicine at the University of Arizona Andrew Weil Center for Integrative Medicine.  

Focus Issue on Focus Issue on Cardio-Oncology and Arrhythmias

Join us as we welcome back Dr. Veera Rajagopal, a discovery scientist at Regeneron with an interest in human genetics and drug target discovery in neuroscience and psychiatry. If you're a regular listener of The Genetics Podcast, you may be familiar with Dr. Veera's annual round-up episodes, and more recently, his quarterly appearances on the show. We're pleased to bring you the latest quarterly roundup, during which Dr. Veera and Patrick walk through the most recent developments in genetics, drug discovery, and precision medicine. In this episode, Dr. Veera and Patrick dive into a wide variety of topics, including: - The evolution of skin color in humans - The potential of a novel tau isoform for Alzheimer's treatment - Protective mechanisms of tomoregulin-1 against herpes simplex virus - The discovery of a new noncoding Mendelian disease mechanism linked to cardiac arrhythmias - A comparative analysis of whole genome versus whole exome sequencing for gene discovery. Tune in now, and don't forget to check out Veera's substack, GWAS Stories, and his Twitter, @doctorveera. Additionally, we're excited to invite you to an in-person meetup for The Genetics Podcast during the ASHG Annual Meeting in Denver, CO! Over the years, we've had the honor of speaking with leading voices across science, industry, patient advocacy, and policy. Now, we're bringing this incredible community together face-to-face. Join us on the evening of Thursday, November 7. To RSVP, visit: https://lu.ma/geneticspodASHG.

Focus Issue on Genetics and Arrhythmias

With Viviana Maestrini, Sapienza University of Rome - Italy and Sara Monosilio, Sapienza University of Rome - Italy. Link to paper Link to editorial

This week we listen in on a wonderful review lecture on fetal arrhythmias by noted fetal cardiologist Professor Bettina Cuneo. In this lecture Dr. Cuneo reviews the basics of fetal tachycardias and bradycardias and how these arrhythmias are diagnosed and sometimes treated. This is a lecture that was delivered on 9/20/24 by Dr. Cuneo at the Pedirhythm XI meeting in Rome, Italy. Thanks go to Dr. Fabrizio Drago and the organizers of Pedirhythm for allowing us to listen in on this wonderful lecture by a world-wide authority.